Evidence Hub

Sex Differences in Helicobacter pylori Antimicrobial Resistance among 890 Subjects over 20 Years in a Korean Tertiary Hospital

Choi Y, Kim N, Lee JY, Lee JW, Lee HD, Lee J, Jo SY, Nam RH et al.

Gut and liver, 2026

890 participants

Abstract

Background/aims: Although sex-based differences in Helicobacter pylori eradication success rates and antibiotic resistance profiles have been suggested, which are essential for effective eradication of H. pylori, evidence remains limited. The aim of this study was to investigate sex-based differences in antibiotic resistance patterns of H. pylori to better inform eradication strategies.

Methods: Subjects from whom H. pylori colonies were isolated from gastric mucosal biopsy specimens were consecutively enrolled between 2003 and 2025. Minimum inhibitory concentration tests were performed for amoxicillin, clarithromycin, metronidazole, tetracycline, levofloxacin, and moxifloxacin using the agar dilution method.

Results: A total of 890 subjects (510 males and 380 females) were included. Females demonstrated higher resistance rates to clarithromycin (50.0% vs 35.9%; p<0.001), metronidazole (45.3% vs 38.4%; p=0.041), levofloxacin (45.8% vs 33.7%; p<0.001), and moxifloxacin (45.5% vs 34.1%; p=0.001) than males did; however, no significant differences were found for amoxicillin or tetracycline. Stratified analyses revealed significant sex differences in resistance to clarithromycin and levofloxacin among secondary strains (clarithromycin, 80.9% vs. 67.2%, p=0.007; levofloxacin, 61.1% vs. 48.9%, p=0.034), whereas metronidazole resistance among primary strains showed only a marginal sex difference (40.8% vs. 33.2%, p=0.064). Females also demonstrated significantly higher rates of…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free